Atherectomy and Drug-Coated Balloon Angioplasty for the Treatment of Long Infrapopliteal Lesions: A Randomized Controlled Trial

医学 血管成形术 动脉切除术 随机对照试验 气球 外科 切割气球 再狭窄 放射科 支架
作者
Aljoscha Rastan,Marianne Brodmann,Tanja Böhme,Roland Macharzina,Elias Noory,Ulrich Beschorner,Peter-Christian Flügel,Karlheinz Bürgelin,Franz‐Josef Neumann,Thomas Zeller
出处
期刊:Circulation-cardiovascular Interventions [Lippincott Williams & Wilkins]
卷期号:14 (6) 被引量:23
标识
DOI:10.1161/circinterventions.120.010280
摘要

Background: Prospective, randomized, multicenter trials show no beneficial impact of drug-coated balloon (DCB) therapy alone on the technical and clinical outcomes of infrapopliteal artery lesions in comparison to plain old balloon angioplasty. The aim of this study was to evaluate the performance of directional atherectomy (DA) plus DCB angioplasty versus DCB alone in treatment of long infrapopliteal artery lesions. Methods: We conducted a prospective, randomized, 2-center trial comparing the performance of DA+DCB and DCB alone in treatment of 80 patients with de novo infrapopliteal artery lesions. The primary study end point was the 6-month primary patency of the target lesion detected by angiography and duplex ultrasound. Secondary end points included clinically driven target vessel revascularization, amputation rates, and changes in Rutherford-Becker class at 1 year. A core laboratory provides independent analyses for all scheduled and unscheduled duplex ultrasound examinations and angiographies, and a research institute ensured independent data collection. Results: The mean target lesion length was 179.7±98.2 mm. Nine patients (11.3%) died during the follow-up period. At 6 months, primary patency was 49% (n=18) with DA+DCB versus 34% (n=12) with DCB alone ( P =0.241), and clinically driven target vessel revascularization was 8% (n=3) versus 14% (n=5; P =0.475), respectively. At 1 year, the target lesion revascularization rates were 30% (n=10) versus 43% (n=12; P =0.308), the median in Rutherford-Becker class was 2 (0.25–5) versus 5 (0.25–5; P =0.329), and amputation rates were 22% (n=8) versus 32% (n=11; P =0.618) in the DA+DCB group and the DCB group, respectively. Conclusions: Treatment of long infrapopliteal artery lesions with DA+DCB versus DCB alone leads to comparable clinical and technical results at 6 months and 1 year. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01763476.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
睡觉了完成签到 ,获得积分10
1秒前
量子星尘发布了新的文献求助10
2秒前
乖猫要努力应助精明寻梅采纳,获得10
2秒前
AI完成签到,获得积分10
5秒前
xiaosu发布了新的文献求助30
6秒前
6秒前
谢琉圭完成签到,获得积分10
8秒前
领导范儿应助稳重的若雁采纳,获得10
11秒前
11秒前
12秒前
wu完成签到,获得积分20
12秒前
momo发布了新的文献求助10
13秒前
14秒前
田様应助123采纳,获得10
14秒前
18秒前
zying完成签到,获得积分10
21秒前
22秒前
双楠应助wangjue采纳,获得10
22秒前
27秒前
雪白尔岚发布了新的文献求助10
31秒前
31秒前
31秒前
慕青应助momo采纳,获得10
32秒前
从容冰夏完成签到,获得积分10
34秒前
34秒前
桐桐应助Candy采纳,获得10
35秒前
YR完成签到,获得积分10
37秒前
欧阳月空发布了新的文献求助10
37秒前
周em12_发布了新的文献求助10
38秒前
糊涂涂完成签到 ,获得积分10
38秒前
39秒前
41秒前
Zhang完成签到,获得积分10
42秒前
43秒前
43秒前
44秒前
45秒前
圆锥香蕉给ZEcholy的求助进行了留言
46秒前
jisujun发布了新的文献求助10
46秒前
李小宁发布了新的文献求助10
46秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989334
求助须知:如何正确求助?哪些是违规求助? 3531428
关于积分的说明 11253936
捐赠科研通 3270119
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173